MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech Unfiltered: Pedersen Talks Trump and FDA

TAGS: Regulations
News Editor Amanda Pedersen shares her take on the Trump administration's decision to limit FDA regulation of lab-developed tests.

In case you missed it, here is this week's Medtech Unfiltered.

Medtech Unfiltered is a weekly discussion on MD+DI's Facebook page every Tuesday beginning at 11 a.m. Eastern Time, about what matters most in medtech at the moment. In the interest of time, these discussions will be 15 minutes or less.

Next week we will talk about the convalescent plasma saga and the importance of political independence at FDA. Read MD+DI Managing Editor Omar Ford's report here, then join us Tuesday for a candid conversation about President Trump's relationship with FDA and the Centers for Disease Control and Prevention. Viewers are encouraged to ask questions and share their perspectives via the comments section during the live stream. You may also email your question or comment in advance to amanda.pedersen@informa.com using the subject line “Medtech Unfiltered,” or send a text to 310-266-1323.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish